HYAC
Haymaker Acquisition Corp. 4 · Financials · Shell Companies
Last
$11.45
−$0.01 (−0.09%) 4:00 PM ET
After hours $11.47 +$0.02 (+0.17%) 8:30 PM ET
Prev close $11.46
Open $11.47
Day high $11.47
Day low $11.45
Volume 615
Avg vol 91,445
Mkt cap
$334.64M
P/E ratio
38.17
EPS
0.30
Sector
Financials
AI report sections
HYAC
Haymaker Acquisition Corp. 4
HYAC exhibits very low price volatility with a steady upward drift over the past year, trading near the top of its 52-week range and slightly above key short-term moving averages. At the same time, fundamental metrics show negative operating income, shrinking earnings, and very weak liquidity ratios, contrasting with a relatively high earnings multiple. Short interest is minimal, but the extremely high short volume ratio on a recent day points to episodic order-flow concentration that may not reflect broad conviction.
AI summarized at 2:13 PM ET, 2026-02-03
AI summary scores
INTRADAY: 55 SWING: 62 LONG: 38
Volume vs average
Intraday (cumulative)
−99% (Below avg)
Vol/Avg: 0.01×
RSI
62.43 (Strong)
Strong (60–70)
MACD momentum
Intraday
-0.00 (Weak)
MACD: -0.00 Signal: -0.00
Short-Term
-0.00 (Weak)
MACD: 0.01 Signal: 0.01
Long-Term
+0.00 (Strong)
MACD: 0.03 Signal: 0.03
Intraday trend score 60.14

Latest news

HYAC 2 articles Positive: 0 Neutral: 0 Negative: 0
Unknown GlobeNewswire Inc. • Haymaker Acquisition Corp. III
Haymaker Acquisition Corp. III Announces Stockholder Approval of Business Combination with Biote

NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Haymaker Acquisition Corp. III (Nasdaq: HYAC) (“Haymaker” or the “Company”), a publicly traded special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination (the “Business Combination”) with Biote, and the related proposals, at Haymaker’s special meeting held on May 24, 2022. A Form 8-K disclosing the full voting results has been filed with the Securities and Exchange Commission.

HYACU HYACW HYAC Business Contracts
Unknown GlobeNewswire Inc. • Haymaker Acquisition Corp. III
Biote Reports Record Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Outlook

IRVING, Texas, March 22, 2022 (GLOBE NEWSWIRE) -- Biote, a high growth, differentiated medical practice-building business within the hormone optimization space, today announced record financial results for the fourth quarter and full year of 2021.

HYACU HYACW HYAC Earnings Releases and Operating Results
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal